Cramer's 'Mad Money' Recap: Think Big
Bush also discussed the recent acquisition of Epocrates (EPOC), a provider of medical and drug information with over one million users that include over 330,000 doctors. Bush said that Epocrates does over 200 million drug lookups and is the most trusted name in online medical information.
When asked how much money could be saved by moving to online records and services, Bush said our health-care system could easily save 25% to 30% just by not handling claims multiple times and making multiple requests for information. He said our health-care system today doesn't connect information with patients, something it desperately needs to do.
Cramer said that while Athenahealth is expensive, it's also best of breed and will continue heading higher.
No Huddle Offense
In his "No Huddle Offense" segment, Cramer once again proved to viewers why speculation should be a part of their portfolios. He said even he's been amazed at how single-digit stocks like Sprint, Clearwire and Nokia (NOK) have been able to deliver triple-digit returns for those to braved the lows in 2012.
As SuperValu proved today, there's a price at which even the most hated and troubled of companies becomes attractive, but other those investors willing to speculate are able to cash in on these spectacular returns. To sign up for Jim Cramer's free Booyah! newsletter with all of his latest articles and videos please click here. To watch replays of Cramer's video segments, visit the Mad Money page on CNBC. -- Written by Scott Rutt in Washington, D.C. To email Scott about this article, click here: Scott Rutt Follow Scott on Twitter @ScottRutt or get updates on Facebook, ScottRuttDCSelect the service that is right for you!
COMPARE ALL SERVICESAction Alerts PLUS
TRY IT FREEJim Cramer and Stephanie Link actively manage a real portfolio and reveal their money management tactics while giving advanced notice before every trade.
Product Features:
- $2.5+ million portfolio
- Large-cap and dividend focus
- Intraday trade alerts from Cramer
- Weekly roundups
TheStreet Quant Ratings
TRY IT FREENew! $49.95/yr
Access the tool that DOMINATES the Russell 2000 and the S&P 500.
Product Features:
- Buy, hold, or sell recommendations for over 4,300 stocks
- Unlimited research reports on your favorite stocks
- A custom stock screener
- Upgrade/downgrade alerts
Stocks Under $10
TRY IT FREEDavid Peltier, uncovers low dollar stocks with extraordinary upside potential that are flying under Wall Street's radar.
Product Features:
- Model portfolio
- Stocks trading below $10
- Intraday trade alerts
- Weekly roundups
Dividend Stock Advisor
TRY IT FREEJim Cramer's protege, David Peltier, identifies the best of breed dividend stocks that will pay a reliable AND significant income stream.
Product Features:
- Diversified model portfolio of dividend stocks
- Alerts when market news affect the portfolio
- Bi-weekly updates with exact steps to take - BUY, HOLD, SELL
Real Money Pro
TRY IT FREEAll of Real Money, plus 15 more of Wall Street's sharpest minds delivering actionable trading ideas, a comprehensive look at the market, and fundamental and technical analysis.
Product Features:
- Real Money + Doug Kass + 15 more Wall Street Pros
- Intraday commentary & news
- Ultra-actionable trading ideas
Options Profits
TRY IT FREEOur options trading pros provide daily market commentary and over 100 monthly option trading ideas and strategies to help you become a well-seasoned trader.
Product Features:
- 100+ monthly options trading ideas
- Actionable options commentary & news
- Real-time trading community
- Options TV